Announcements Trials

Browse Landscape

Phase

Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Completed 135 Active not recruiting 62 Terminated 46 Recruiting 44 Unknown 22 Withdrawn 14 Not yet recruiting 6 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Advanced Renal Cell Carcinoma 1

Interventions

Specimen Handling 9 Magnetic Resonance Spectroscopy 7 Biopsy 6 Nivolumab 4 Capecitabine 4 Bevacizumab 4 Radiosurgery 3 Paclitaxel 3 Irinotecan 3 Fluorouracil 3 Everolimus 3 Docetaxel 3 Cyclophosphamide 3 Cisplatin 3 trifluridine tipiracil drug combination 2 spartalizumab 2 pembrolizumab 2 lenvatinib 2 decitabine and cedazuridine drug combination 2 daratumumab 2 Vincristine 2 Taxes 2 Radiation 2 Prednisone 2 Pemetrexed 2 Oxaliplatin 2 Mitoxantrone 2 Leucovorin 2 Etoposide 2 Epirubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Ipilimumab × Clear all

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡